Abstract:Amorphous Solid Dispersions (ASDs) have indeed revolutionized the pharmaceutical industry, particularly in drug solubility enhancement. The amorphous state of a drug, which is a highenergy metastable state, can lead to an increase in the apparent solubility of the drug. This is due to the absence of a long-range molecular order, which results in higher molecular mobility and free volume, and consequently, higher solubility. The success of ASD preparation depends on the selection of appropriate excipients, particularly polymers that play a crucial role in drug solubility and physical stability. However, ASDs face challenges due to their thermodynamic instability or tendency to recrystallize. Measuring the crystallinity of the active pharmaceutical ingredient (API) and drug solubility is a complex process that requires a thorough understanding of drug-polymer miscibility and molecular interactions. Therefore, it is important to monitor drug solids closely during preparation, storage, and application. Techniques such as solid-state nuclear magnetic resonance (ssNMR), attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR), Raman spectroscopy, and dielectric spectroscopy have been successful in understanding the mechanism of drug crystallization. In addition, the continuous downstream processing of drug-loaded ASDs has introduced new automated methods for consistent ASD production. Advanced techniques such as hot melt extrusion, KinetiSol, electro spraying, and electrospinning have gained popularity. This review provides a comprehensive overview of Amorphous Solid Dispersions (ASDs) for oral drug delivery. It highlights the critical challenges faced during formulation, the impact of manufacturing variables, theoretical aspects of drug-polymer interaction, and factors related to drug-polymer miscibility. ASDs have been recognized as a promising strategy to improve the oral bioavailability of poorly water-soluble drugs. However, the successful development of an ASD-based drug product is not straightforward due to the complexity of the ASD systems. The formulation and process parameters can significantly influence the performance of the final product. Understanding the interactions between the drug and polymer in ASDs is crucial for predicting their stability and performance.

Counter‐intuitive discovery in the formulation of poorly water‐soluble drugs: Amorphous small‐molecule gels

Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review

Drug-drug co-amorphous systems: An emerging formulation strategy for poorly water-soluble drugs

Increasing the Dissolution Rate of A Low-Solubility Drug Through A Crystalline-Amorphous Transition: A Case Study with Indomethicin

Mechanistic insight into gel formation of co-amorphous resveratrol and piperine during dissolution process

"Felodipine-Indomethacin" Co-Amorphous Supersaturating Drug Delivery Systems: "Spring-Parachute" Process, Stability, in Vivo Bioavailability, and Underlying Molecular Mechanisms

The State of Water and Its Impact on Pharmaceutical Systems: Lipid-Based Drug Delivery Systems and Amorphous Solids

Self-nanomicellizing solid dispersion: A promising platform for oral drug delivery

Study on co-amorphous emerging solubilization behavior after gelation during dissolution: The importance of complexation and anti-crystallization

Amorphous solid dispersion to facilitate the delivery of poorly water-soluble drugs: recent advances on novel preparation processes and technology coupling

The importance of surface composition and wettability on the dissolution performance of high drug loading amorphous dispersion formulations

Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates

Amorphous systems for delivery of nutraceuticals: challenges opportunities

Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions

β-Lactoglobulin-based amorphous solid dispersions: A graphical review on the state-of-the-art

Hot-melt Extrusion Promotes Dissolution, Extends "Spring-Parachute" Process and Inhibits Crystallization in Supersaturating Microparticle Systems

Unraveling the complexity of amorphous solid as direct ingredient for conventional oral solid dosage form: The story of Elagolix Sodium

An Examination of Water Vapor Sorption by Multicomponent Crystalline and Amorphous Solids and Its Effects on Their Solid-State Properties

Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology

Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies

Mechanisms of dissolution and crystallization of amorphous glibenclamide